α2δ-1Ligand DS5565; DS-5565 ;Mirogabalin Besilate CAS Number 1138245-21-2

    Mirogabalin besilate CAS number is 1138245-21-2, which was developed by Daiichi Sankyo Pharmaceutical Co., Ltd., was approved for listing on January 8, 2019 by the Japan Pharmaceuticals and Medical Device Comprehensive Agency (PMDA) under the trade name Tarlige. In July 2015, Daiichi Sankyo submitted a clinical application for Mirogabalin besilate to the Chinese CDE. Phase III clinical trials have started in June 2019 in China. Mirogabalin besilate CAS 1138245-21-2 is a calcium channel α2δ ligand that binds to the α2δ subunit of calcium channels that are widely present in the nervous system that mediates pain and is approved for the treatment of diabetic peripheral neuropathic pain (DPNP) . Mirogabalin besilate CAS number 1138245-21-2, along with gabapentin and pregabalin, belong to the class of drugs called gabapentinoid, but the efficacy is significantly higher than pregabalin.

Thera. Category:  Anti diabetic

Cas No.: 1138245-21-2

Synonym: MIROGABALIN BENZENESULFONIC ACID;1138245-21-2

Molecular Formula:C18H25NO5S

Molecular Weight:367.4598

Assay: ≥98.%

Packing:Export worthy packing

Material Safety Data Sheet:Available on request

Usage: Mirogabalin Besilate Novel α2δ-1 ligand for the treatment of diabetic peripheral neuropathic pain

We are on the supplying intermediate for Mirogabalin Besilate as below:
  1)  (1R,5S)-3-ethyl-Bicyclo[3.2.0]hept-3-en-6-one 1235479-61-4

       2)  1138245-13-2,Mirogabalin

       3)  Mirogabalin Besilate Cas 1138245-21-2